Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials
Background Despite global containment measures to fight the coronavirus disease 2019 (COVID-19), the pandemic continued to rise, rapidly spread across the world, and resulting in 2.6 million confirmed cases and 185 061 deaths worldwide as of 23 April 2020. Yet, there are no approved vaccines or drug...
Main Authors: | Desye Gebrie, Desalegn Getnet, Tsegahun Manyazewal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/6/e039159.full |
Similar Items
-
Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials
by: Desye Gebrie, et al.
Published: (2021-01-01) -
Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials
by: Yuki Enoki, et al.
Published: (2021-03-01) -
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
by: Alejandro Piscoya, et al.
Published: (2020-01-01) -
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
by: Piscoya, Alejandro, et al.
Published: (2021) -
Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis
by: Mohammad Tasavon Gholamhoseini, et al.
Published: (2021-05-01)